Ampicillin: Difference between revisions
(Text replacement - "==Source==" to "==References==") |
(added dosage form, dosage strength, route of administration, trade name) |
||
Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: [[Penicillin]] | *Type: [[Penicillin]] | ||
*Dosage Forms: | *Dosage Forms: capsule, oral suspension, powder for injection | ||
*Common Trade Names: | *Dosage Strengths: capsule: 250, 500mg; oral suspension: 125, 250mg/5mL; powder for injection: 125mg, 250mg, 500mg, 1g, 2g, 10g | ||
*Routes of Administration: PO, IV, IM | |||
*Common Trade Names: Ampi, Omnipen, Penglobe, Principen | |||
==Adult Dosing== | ==Adult Dosing== |
Revision as of 20:04, 11 October 2017
General
- Type: Penicillin
- Dosage Forms: capsule, oral suspension, powder for injection
- Dosage Strengths: capsule: 250, 500mg; oral suspension: 125, 250mg/5mL; powder for injection: 125mg, 250mg, 500mg, 1g, 2g, 10g
- Routes of Administration: PO, IV, IM
- Common Trade Names: Ampi, Omnipen, Penglobe, Principen
Adult Dosing
Pediatric Dosing
Pneumonia (peds)
- 150-200mg/kg/day IV divided Q6hours (max dose: 4g per day)
Special Populations
- Pregnancy:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014